AIV001

DRUG4 trials

Sponsors

AiViva BioPharma, Inc.

Conditions

AbdominalExcision MarginIncisionKeloidNodular Basal Cell CarcinomaNonmelanoma Skin CancersPapulopustular RosaceaScar

Phase 1

A Safety and Efficacy Study to Evaluate AIV001 in Wound Healing Following Surgical Incision

CompletedNCT03639883

AiViva BioPharma, Inc.Abdominal, Incision, Scar +1

Start: 2018-11-05End: 2019-12-19Updated: 2024-12-24

A Safety and Efficacy Study to Evaluate Rosacea

WithdrawnNCT03883945

AiViva BioPharma, Inc.Papulopustular Rosacea

Start: 2021-07-31End: 2022-08-31Updated: 2024-12-17

Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype

CompletedNCT04470726

AiViva BioPharma, Inc.Nodular Basal Cell Carcinoma, Nonmelanoma Skin Cancers, Superficial Basal Cell Carcinoma

Start: 2020-08-18End: 2023-07-28Updated: 2024-12-27

Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy

CompletedNCT04827875

AiViva BioPharma, Inc.Excision Margin, Incision, Keloid +1

Start: 2021-06-23End: 2022-12-15Updated: 2024-12-27